fleroxacin has been researched along with Recrudescence in 2 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical efficacy of fleroxacin (FLRX), a new fluoroquinolone, for acute uncomplicated cystitis (AUC) in women was assessed." | 9.08 | [Fleroxacin treatment for acute uncomplicated cystitis in women: comparison of 3-day and 7-day therapy]. ( Ban, Y; Doi, T; Fujihiro, S; Hasegawa, Y; Ishihara, S; Ito, F; Ito, S; Ito, Y; Iwata, H; Kawada, Y; Koide, T; Minoshima, K; Nezasa, S; Sakai, S; Shinoda, I; Takeuchi, T; Taniguchi, M; Ueno, K; Uno, H; Yamaha, M, 1998) |
| "Fleroxacin, 400 mg once daily, and norfloxacin, 400 mg twice daily, both administered orally, were compared for the treatment of serious urinary tract infections (UTIs)." | 9.07 | Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections. ( Childs, SJ, 1993) |
| "The clinical efficacy of fleroxacin (FLRX), a new fluoroquinolone, for acute uncomplicated cystitis (AUC) in women was assessed." | 5.08 | [Fleroxacin treatment for acute uncomplicated cystitis in women: comparison of 3-day and 7-day therapy]. ( Ban, Y; Doi, T; Fujihiro, S; Hasegawa, Y; Ishihara, S; Ito, F; Ito, S; Ito, Y; Iwata, H; Kawada, Y; Koide, T; Minoshima, K; Nezasa, S; Sakai, S; Shinoda, I; Takeuchi, T; Taniguchi, M; Ueno, K; Uno, H; Yamaha, M, 1998) |
| "Fleroxacin, 400 mg once daily, and norfloxacin, 400 mg twice daily, both administered orally, were compared for the treatment of serious urinary tract infections (UTIs)." | 5.07 | Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections. ( Childs, SJ, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Childs, SJ | 1 |
| Ishihara, S | 1 |
| Ban, Y | 1 |
| Kawada, Y | 1 |
| Ito, S | 1 |
| Ito, Y | 1 |
| Doi, T | 1 |
| Nezasa, S | 1 |
| Fujihiro, S | 1 |
| Yamaha, M | 1 |
| Ito, F | 1 |
| Iwata, H | 1 |
| Hasegawa, Y | 1 |
| Ueno, K | 1 |
| Shinoda, I | 1 |
| Taniguchi, M | 1 |
| Minoshima, K | 1 |
| Takeuchi, T | 1 |
| Sakai, S | 1 |
| Uno, H | 1 |
| Koide, T | 1 |
2 trials available for fleroxacin and Recrudescence
| Article | Year |
|---|---|
Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Flero | 1993 |
[Fleroxacin treatment for acute uncomplicated cystitis in women: comparison of 3-day and 7-day therapy].
Topics: Adult; Aged; Anti-Infective Agents; Cystitis; Drug Administration Schedule; Female; Fleroxacin; Huma | 1998 |